Evidence map›Paper›PMID 38666978›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Characterizing Antibiotic Regimen Modification Behavior, Patient Characteristics, and Outcomes for Patients with Gram-Negative Bacterial Infections, A Retrospective Single-Center Study.

Jason Yamaki, Mirna Mikhail, Richard Beuttler, Philip Robinson, Emre Yücel, Alexandre H Watanabe

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jason YamakiDepartment of Pharmacy Practice, Chapman University School of Pharmacy (CUSP), Irvine, CA 92618, USA.
Mirna MikhailDepartment of Pharmacy Practice, Chapman University School of Pharmacy (CUSP), Irvine, CA 92618, USA.
Richard BeuttlerDepartment of Pharmacy Practice, Chapman University School of Pharmacy (CUSP), Irvine, CA 92618, USA.
Philip RobinsonHoag Memorial Hospital, Newport Beach, CA 92663, USA.
Emre YücelMerck & Co., Inc., Rahway, NJ 07065, USA.
Alexandre H WatanabeMerck & Co., Inc., Rahway, NJ 07065, USA.
Chapman University · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USHoag Memorial Hospital Presbyterian · US

Funding

Merck Sharp & Dohme VEAP8908
6 · The paper itself

Abstract

Few studies describe the frequency of antibiotic regimen modification behaviors in the acute care setting. We sought to ascertain patient and treatment characteristics, details of regimen modification, and clinical outcomes with antibiotic modifications. This retrospective study included patients admitted to Hoag Memorial Hospital from 1 January 2019-31 March 2021 with a complicated infection caused by a Gram-negative organism resistant to extended-spectrum cephalosporins or with the potential for resistance (AmpC producers). A total of 400 patients were included. The predominant sources were bloodstream (33%), urine (26%), and respiratory (24%), including patients with multiple sources. The most isolated organisms were

Indexed as

antibioticsGram-negativeMDROoutcomesprescribing behaviorsstewardship

Identifiers

PMID38666978
PMCPMC11047705
OpenAlexW4393235525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.